Prevalence, characteristics, and associated risk factors of drug consumption and chemsex use among individuals attending an STI clinic (EpITs STUDY)

Sex-related drug consumption and its health-related consequences have gained relevance in the assessment of patients with sexually transmitted infections (STIs), which pose a significant challenge to public health. We aim to assess the prevalence and characteristics of drug consumption and chemsex p...

Full description

Bibliographic Details
Published in:	Frontiers in Public Health
Main Authors:	Marta Rosas Cancio-Suárez, Raquel Ron, Jorge Díaz-Álvarez, Javier Martínez-Sanz, Sergio Serrano-Villar, Santiago Moreno, Matilde Sánchez-Conde
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-10-01
Subjects:	sexually transmitted infections chemsex drug use prevalence risk factors interventions
Online Access:	https://www.frontiersin.org/articles/10.3389/fpubh.2023.1285057/full

Similar Items

From Innovation to Implementation: The Evolution of HIV Pre-Exposure Prophylaxis and Future Implications
by: Marta Rosas Cancio-Suárez, et al.
Published: (2023-07-01)

Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility
by: Oihane E. Albóniga, et al.
Published: (2023-09-01)

Author Correction: Differential abundance of lipids and metabolites related to SARS-CoV-2 infection and susceptibility
by: Oihane E. Albóniga, et al.
Published: (2023-12-01)

Cervical microbiota diversity and functional shifts in the development of cervical high-grade squamous intraepithelial lesions
by: Marta Rosas Cancio-Suárez, et al.
Published: (2025-10-01)

A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease
by: Javier Martínez-Sanz, et al.
Published: (2023-12-01)

CATHINONES AND VIAGRA IN CHEMSEX: AN AUTOETHNOGRAPHY OF TOUCH, MASCULINITIES AND AESTHETICS
by: Jorge Humberto Lucero Díaz
Published: (2025-02-01)

Role of ACE2 genetic polymorphisms in susceptibility to SARS-CoV-2 among highly exposed but non infected healthcare workers
by: Javier Martínez-Sanz, et al.
Published: (2021-01-01)

Chemsex and Barebacking: An Autoethnography of Sexual Panic on an Off-Road Motorbike
by: Jorge Humberto Lucero Díaz
Published: (2025-02-01)

Implementation of a lung cancer screening initiative in HIV-infected subjects.
by: Jorge Díaz-Álvarez, et al.
Published: (2021-01-01)

Is It Time for Treatment as Prevention of Chronic Hepatitis B?
by: Jose A. Perez-Molina, et al.
Published: (2023-09-01)

Chlamydia Trachomatis Prevalence in Asymptomatic Women in Madrid: Study Findings and Their Association with Risk Factors and Mental Health
by: Marta Rosas Cancio-Suárez, et al.
Published: (2024-09-01)

Response to Commentary: Long-term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens
by: Sergio Serrano-Villar, et al.
Published: (2022-06-01)

Chemsex drugs: More than ghb, mephedrone and methamphetamine?
by: J. Curto Ramos, et al.
Published: (2021-04-01)

Chemsex and Psychosis: A Systematic Review
by: Lucía Moreno-Gámez, et al.
Published: (2022-12-01)

Sexual counselling and sexual therapy in chemsex users in an NGO in spain
by: J. Curto Ramos, et al.
Published: (2021-04-01)

Dangers of Chemsex: an autopsy case report
by: A. Levasseur, et al.
Published: (2024-07-01)

Corrigendum: CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis
by: Raquel Ron, et al.
Published: (2024-02-01)

CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis
by: Raquel Ron, et al.
Published: (2024-02-01)

Global DNA methylation and telomere length as markers of accelerated aging in people living with HIV and non-alcoholic fatty liver disease
by: Elena Moreno, et al.
Published: (2023-09-01)

Penile Ulceration After Local Injection of Metaphedrone During Chemsex
by: Dorian Bettin, et al.
Published: (2025-06-01)

Attachment style, ways of coping with stress and life attitudes by MSM who are active chemsex users
by: P. Kaluzny, et al.
Published: (2022-06-01)

An online study to understand chemsex in India
by: Varsha Sriperambudoori, et al.
Published: (2025-05-01)

“New” drugs associated with chemsex? 2C-B in sexual context. A case report and review
by: J. Curto Ramos, et al.
Published: (2021-04-01)

Needs and experiences of people practising chemsex with support services: toward chemsex-affirmative interventions
by: Yannick Gaudette, et al.
Published: (2023-12-01)

Re-pensar el chemsex
by: Iván Gallardo Esclapez
Published: (2023-07-01)

Chemsex, G&T, and The Club Drugs Clinic Ireland
by: K. Santlal, et al.
Published: (2022-06-01)

South African harm reduction guideline for chemsex
by: Andrew Scheibe, et al.
Published: (2025-09-01)

El sujeto chemsex en el discurso psicobiomédico y el discurso multimodal gestual de la obra de teatro El Gé
by: Jorge Humberto Lucero Díaz, et al.
Published: (2025-05-01)

HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases
by: Sabina Herrera, et al.
Published: (2019-06-01)

Utilization of mental health services in relation to the intention to reduce chemsex behavior among clients from an integrated sexual health services center in Taiwan
by: Yu-Ru Hung, et al.
Published: (2023-04-01)

Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations
by: Alexy Inciarte, et al.
Published: (2024-04-01)

Differences between men who have sex with men that use drugs and engage in chemsex and those who do not engage in chemsex in the French ANRS-PREVENIR cohort: the need to rethink harm reduction services
by: Luis Sagaon-Teyssier, et al.
Published: (2025-08-01)

The role of attachment in sexualised polydrug use among LGBT+ male Chemsex users and the impact on Neuropsychology: Clinical implications for the use of Mentalisation Based Therapy (MBT)
by: Christopher Cartner
Published: (2022-01-01)

A 12-week multicomponent exercise program enhances frailty by increasing robustness, improves physical performance, and preserves muscle mass in older adults with HIV: MOVIhNG study
by: Fátima Brañas, et al.
Published: (2024-04-01)

Pre-exposure prophylaxis (PrEP) against HIV: efficacy, safety and uncertainties
by: Santiago Moreno Guillen, et al.
Published: (2017-09-01)

Exploration of Mental Health Elements in Chemsex Behavior: Interventions, Influencing Factors, and Attitudes towards Risk and Harm Reduction in Spain
by: Pablo Del Pozo-Herce, et al.
Published: (2024-09-01)

Social capital and chemsex initiation in young gay, bisexual, and other men who have sex with men: the pink carpet Y cohort study
by: Rayner Kay Jin Tan, et al.
Published: (2021-02-01)

Long-Term Health Outcomes of People with HIV Engaged in Chemsex: A Prospective Cohort Study on Drug Use, Sexual Behaviour, Sexually-Transmitted Infections and Vulnerability
by: Lorena De La Mora, et al.
Published: (2025-08-01)

Polydrug use during chemsex: single and intersecting sexual effects of commonly used drugs
by: Tom Platteau, et al.
Published: (2025-07-01)

Drugs Used in “Chemsex”/Sexualized Drug Behaviour—Overview of the Related Clinical Psychopharmacological Issues
by: Fabrizio Schifano, et al.
Published: (2025-04-01)